4-羟基甲基-联苯-4-羧酸 | 49743-87-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-羟基甲基-联苯-4-羧酸
• 中文别名: 4-(4-羟甲基苯基)苯甲酸
• 英文名称: 4-Hydroxymethyldiphenyl-4'-carbonsaeure
• 英文别名: 4'-(Hydroxymethyl)-[1,1'-biphenyl]-4-carboxylic acid；4-[4-(hydroxymethyl)phenyl]benzoic acid
• CAS: 49743-87-5
• 化学式: C₁₄H₁₂O₃
• 分子量: 228.247
• InChiKey: KFUFJTLYVMRPLV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2918199090
• 储存条件：
  室温、密封、干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(4-Hydroxymethylphenyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Hydroxymethylphenyl)benzoic acid
CAS number: 49743-87-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H12O3
Molecular weight: 228.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-羟基甲基-联苯-4-羧酸 在 咪唑 、 二苯基膦叠氮化物 、 四丁基氟化铵 、 三乙胺 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 44.0h， 生成 prop-2-enyl N-[4-[4-(hydroxymethyl)phenyl]phenyl]carbamate
  参考文献：
  名称：

  可激活的抗癌前药中的延长的多个电子级联和环化间隔系统，可增强药物释放。

  摘要：

  描述和设计了几种新颖的用于前药的自消除间隔基系统。这些细长的间隔物系统可以结合在可裂解的指定分子和母体药物之间。合成了含萘和联苯的间隔基，但没有消除。据报道，抗癌药阿霉素和紫杉醇的前药含有两个或三个电子级联间隔基。发现HOBt的一种新型催化应用，用于使碳酸4-硝基苯基酯与苯胺衍生物反应，通过氨基甲酸酯键连接1,6-消除间隔基，从而合成N-芳基氨基甲酸酯。另外，合成了含有双间隔基的紫杉醇前药，其包含1，6-消除间隔基和经由2'-氨基甲酸酯键连接至紫杉醇的双胺连接基。与含有常规间隔物系统的前药相比，在特定的三肽指定剂与母体药物阿霉素或紫杉醇之间掺入了新型间隔物系统的前药被证明可以显着更快地被纤溶酶激活。预期本文报道的普遍适用的新型间隔物系统将有助于改进的酶活化前药的未来开发。

  DOI：

  10.1021/jo0158884
• 作为产物：
  描述：

  联苯二甲酸二甲酯 在 sodium hydroxide 、 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 32.5h， 生成 4-羟基甲基-联苯-4-羧酸
  参考文献：
  名称：

  可激活的抗癌前药中的延长的多个电子级联和环化间隔系统，可增强药物释放。

  摘要：

  描述和设计了几种新颖的用于前药的自消除间隔基系统。这些细长的间隔物系统可以结合在可裂解的指定分子和母体药物之间。合成了含萘和联苯的间隔基，但没有消除。据报道，抗癌药阿霉素和紫杉醇的前药含有两个或三个电子级联间隔基。发现HOBt的一种新型催化应用，用于使碳酸4-硝基苯基酯与苯胺衍生物反应，通过氨基甲酸酯键连接1,6-消除间隔基，从而合成N-芳基氨基甲酸酯。另外，合成了含有双间隔基的紫杉醇前药，其包含1，6-消除间隔基和经由2'-氨基甲酸酯键连接至紫杉醇的双胺连接基。与含有常规间隔物系统的前药相比，在特定的三肽指定剂与母体药物阿霉素或紫杉醇之间掺入了新型间隔物系统的前药被证明可以显着更快地被纤溶酶激活。预期本文报道的普遍适用的新型间隔物系统将有助于改进的酶活化前药的未来开发。

  DOI：

  10.1021/jo0158884

文献信息

• [EN] 2,6-DISUBSTITUTED PYRIDINES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS<br/>[FR] PYRIDINES 2,6-DISUBSTITUÉES COMME ACTIVATEURS DE LA GUANYLATE CYCLASE SOLUBLE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009071504A1

  公开（公告）日：2009-06-11

  Disclosed are compounds of formula (I) wherein R1 and R2 are independently selected from hydrogen, halo, CF3, C1-4alkyl and allyl; Y represents (II), (III), (IV) or (V) wherein R3 represents CF3 or C1-4alkyl; and R3a represents CF3 or C1-4alkyl.

  公开的是式（I）的化合物，其中R1和R2分别选自氢、卤素、CF3、C1-4烷基和烯丙基；Y代表（II）、（III）、（IV）或（V），其中R3代表CF3或C1-4烷基；而R3a代表CF3或C1-4烷基。
• Acceptorless dehydrogenation of primary alcohols to carboxylic acids by self-supported NHC-Ru single-site catalysts
  作者：Shenxiang Yin、Qingshu Zheng、Jie Chen、Tao Tu

  DOI：10.1016/j.jcat.2022.02.018

  日期：2022.4

  aliphatic primary alcohols to corresponding carboxylic acids has been accomplished by self-supported NHC-Ru single-site catalysts under mild reaction conditions. Besides broad substrates with excellent activity, selectivity and good tolerance to sensitive functional groups, the solid single-site catalyst could be recovered and reused for more than 20 runs without deactivation. Remarkably, up to 1.8 × 10

  通过自支撑NHC-Ru单中心催化剂在温和的反应条件下实现了多种芳香族和脂肪族伯醇无受体脱氢生成相应的羧酸。除了具有优异活性、选择性和对敏感官能团良好耐受性的广泛底物之外，固体单中心催化剂可以回收并重复使用20次以上而不会失活。值得注意的是，这种新开发的可持续协议在低催化剂负载量下可以实现高达 1.8 × 10 的周转数，凸显了其在工业中的潜力。
• ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR
  申请人：Buchmann Bernd

  公开号：US20090023741A1

  公开（公告）日：2009-01-22

  The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP 2 receptor.

  本发明涉及通式I的芳基/杂环酰胺衍生物，其制备方法，以及用于制造治疗与EP2受体相关的疾病和适应症的药物组合物的用途。
• ANTIBACTERIAL AGENTS
  申请人：Moser Heinz E.

  公开号：US20100190766A1

  公开（公告）日：2010-07-29

  Antibacterial compounds of formula (I) are provided: as well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.

  提供化学式(I)的抗菌化合物：以及其立体异构体，药学上可接受的盐，酯和前药；包含这些化合物的制药组合物；通过给予这些化合物的途径治疗细菌感染的方法；以及制备这些化合物的过程。
• Autohydrolysis of Diglycine‐Activated Succinic Esters Boosts Cellular Uptake
  作者：Jiaqi Guo、Weiyi Tan、Hongjian He、Bing Xu

  DOI：10.1002/anie.202308022

  日期：2023.9.4

  Rapid cellular uptake of synthetic molecules remains a challenge, and the motif frequently employed to generate prodrugs, succinic ester, unfortunately lowers the efficacy of the desired drugs due to their slow ester hydrolysis and low cell entry. Here we show that succinic ester‐containing diglycine drastically boosts the cellular uptake of supramolecular assemblies or prodrugs. Specifically, autohydrolysis of the diglycine‐activated succinic esters turns the nanofibers of the conjugates of succinic ester and self‐assembling motif into nanoparticles for fast cellular uptake. The autohydrolysis of diglycine‐activated succinic esters and drug conjugates also restores the efficacy of the drugs. 2D nuclear magnetic resonance (NMR) suggests that a “U‐turn” of diglycine favors intramolecular hydrolysis of diglycine‐activated succinic esters to promote autohydrolysis. As an example of rapid autohydrolysis of diglycine‐activated succinic esters for instant cellular uptake, this work illustrates a nonenzymatic bond cleavage approach to develop effective therapeutics for intracellular targeting.

  摘要合成分子的快速细胞吸收仍然是一项挑战，而常用于生成原药的基团--琥珀酸酯，却因其缓慢的酯水解和较低的细胞进入率而降低了所需药物的药效。在这里，我们展示了含琥珀酸酯的二甘氨酸能显著提高细胞对超分子组装体或原药的吸收。具体来说，二甘氨酸激活的琥珀酸酯的自水解作用可将琥珀酸酯和自组装基团共轭物的纳米纤维转化为纳米颗粒，使细胞快速吸收。二甘氨酸活化琥珀酸酯和药物共轭物的自水解作用还能恢复药物的药效。二维核磁共振（NMR）表明，二甘氨酸的 "掉头 "有利于二甘氨酸活化琥珀酸酯的分子内水解，从而促进自动水解。作为二甘氨酸活化琥珀酸酯快速自动水解以实现即时细胞摄取的一个实例，这项工作说明了一种非酶键裂解方法，可用于开发有效的细胞内靶向治疗药物。